TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
5.02
+0.27 (5.68%)
At close: Oct 17, 2025, 4:00 PM EDT
5.07
+0.05 (1.00%)
After-hours: Oct 17, 2025, 7:45 PM EDT
TriSalus Life Sciences Market Cap
TriSalus Life Sciences has a market cap or net worth of $250.33 million as of October 17, 2025. Its market cap has increased by 91.92% in one year.
Market Cap
250.33M
Enterprise Value
257.51M
1-Year Change
91.92%
Ranking
Category
Stock Price
$5.02
Market Cap Chart
Since February 8, 2021, TriSalus Life Sciences's market cap has decreased from $328.75M to $250.33M, a decrease of -23.85%. That is a compound annual growth rate of -5.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 250.33M | 63.86% |
| Dec 31, 2024 | 152.77M | -31.30% |
| Dec 29, 2023 | 222.38M | -29.05% |
| Dec 30, 2022 | 313.44M | 1.52% |
| Dec 31, 2021 | 308.75M | -6.08% |
| Feb 8, 2021 | 328.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.73B |
| Johnson & Johnson | 465.34B |
| AbbVie | 405.55B |
| UnitedHealth Group | 322.96B |
| AstraZeneca | 260.83B |
| Novartis AG | 254.64B |
| Novo Nordisk | 237.72B |
| Abbott Laboratories | 223.72B |